Kasvu Therapeutics: Funding, Investors & Team (Sep 2026)
Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Kasvu Therapeutics has raised $34.1M across 1 funding round on record, the most recent a Series A of $34.1M announced in Sep 2026.
That round is above the $5.5M median round size for Finland companies tracked on FundedIQ over the last two years.
Kasvu Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Kasvu Therapeutics Funding Rounds
Kasvu Therapeutics Investors
7 investors are recorded in total; the 5 named above are those the record identifies.
Kasvu Therapeutics Founders and Leadership Team
Contact details for the Kasvu Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Kasvu Therapeutics Funding in Context
Kasvu Therapeutics' latest round of $34.1M is above the median round in Finland. Medians cover the last 24 months of disclosed rounds.
More Funded Startups Like Kasvu Therapeutics
Companies Similar to Kasvu Therapeutics
Verda is a new kind of hyperscaler, with AI at the core. It provides GPU-accelerated virtual machines, bare…
Zero is an AI-powered CRM and sales automation stack for growth companies.
CorneaSense is a medtech startup developing a non-invasive eye sensor to measure ocular hydration for early…
CurifyLabs is a healthtech company focused on the automated compounding of personalized medicines in…
Coolbrook is a manufacturer of naphtha cracking-based reactors. Their technology is intended to replace the…
Our aim is to create competitive advantage by combining brand strategy, customer experience creation, design…
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to…
Lumo Homes will focus on real estate investments in Finland, renewing rental housing to make it increasingly…
Ferrivia Oy is a Finnish health-tech startup specializes in digital health services and personalized tracking…
Userlens is a software development company that helps users to generate feedbacks by analytics and feedback…
We accelerate our customers' business growth by convenience in eMobility with our API-first platform
Kasvu Therapeutics Funding FAQs
What does Kasvu Therapeutics do?
Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
How much funding has Kasvu Therapeutics raised?
Kasvu Therapeutics has raised $34.1M across 1 round on record. The most recent is a Series A of $34.1M announced in Sep 2026.
When did Kasvu Therapeutics last raise funding?
Kasvu Therapeutics' most recent funding round on record is a Series A of $34.1M, announced in Sep 2026.
Who has invested in Kasvu Therapeutics?
Investors on record for Kasvu Therapeutics include Tesi, Innovestor, Hadean Ventures, Nordic Science Investments, Stephen Industries. FundedIQ records 7 investors in total.
Who founded Kasvu Therapeutics?
FundedIQ lists Jami Mandelin (Co-Founder and CEO) at Kasvu Therapeutics.
Where is Kasvu Therapeutics headquartered?
Kasvu Therapeutics is based in Helsinki, Finland.
How many employees does Kasvu Therapeutics have?
Kasvu Therapeutics is in the 11-50 employee band.
About FundedIQ's Kasvu Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kasvu Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.